Biotage 미래 성장
Future 기준 확인 3/6
Biotage (는) 각각 연간 19.5% 및 12.1% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 19.6% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 14.3% 로 예상됩니다.
주요 정보
19.5%
수익 성장률
19.6%
EPS 성장률
Life Sciences 수익 성장 | 44.1% |
매출 성장률 | 12.1% |
향후 자기자본 수익률 | 14.3% |
애널리스트 커버리지 | Low |
마지막 업데이트 | 15 Nov 2024 |
최근 미래 성장 업데이트
Earnings Miss: Biotage AB (publ) Missed EPS By 15% And Analysts Are Revising Their Forecasts
Oct 26Biotage AB (publ) Just Missed EPS By 7.7%: Here's What Analysts Think Will Happen Next
Jul 19Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates
Apr 28Recent updates
Are Investors Undervaluing Biotage AB (publ) (STO:BIOT) By 48%?
Nov 16Earnings Miss: Biotage AB (publ) Missed EPS By 15% And Analysts Are Revising Their Forecasts
Oct 26Investors Interested In Biotage AB (publ)'s (STO:BIOT) Earnings
Sep 17Biotage AB (publ) Just Missed EPS By 7.7%: Here's What Analysts Think Will Happen Next
Jul 19Are Investors Undervaluing Biotage AB (publ) (STO:BIOT) By 39%?
Jun 08Is Biotage AB (publ) (STO:BIOT) Potentially Undervalued?
May 21Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates
Apr 28Biotage's (STO:BIOT) Dividend Will Be SEK1.60
Apr 17Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next
Apr 08Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Apr 03Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Mar 04Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)
Feb 22Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%
Feb 21Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next
Feb 18Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet
Feb 08Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)
Jan 07At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?
Dec 08Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)
Oct 27Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?
Jul 12An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued
Jun 08Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth
May 24Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 05These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely
Mar 12Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?
Feb 21Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?
Jan 06Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly
Dec 03Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?
Oct 27Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)
Oct 07Biotage (STO:BIOT) Could Easily Take On More Debt
Sep 03Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?
Jul 10A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)
Jun 25Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?
May 28Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 23수익 및 매출 성장 예측
날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
---|---|---|---|---|---|
12/31/2026 | 2,757 | 475 | 538 | 669 | 3 |
12/31/2025 | 2,457 | 355 | 314 | 477 | 3 |
12/31/2024 | 2,156 | 255 | 265 | 393 | 3 |
9/30/2024 | 2,117 | 257 | 243 | 406 | N/A |
6/30/2024 | 2,077 | 251 | 261 | 399 | N/A |
3/31/2024 | 1,981 | 236 | 268 | 381 | N/A |
12/31/2023 | 1,862 | 246 | 193 | 284 | N/A |
9/30/2023 | 1,603 | 189 | 148 | 229 | N/A |
6/30/2023 | 1,554 | 216 | 147 | 223 | N/A |
3/31/2023 | 1,541 | 240 | 220 | 295 | N/A |
12/31/2022 | 1,566 | 268 | 271 | 341 | N/A |
9/30/2022 | 1,524 | 240 | 285 | 346 | N/A |
6/30/2022 | 1,428 | 228 | 285 | 338 | N/A |
3/31/2022 | 1,337 | 216 | 290 | 342 | N/A |
12/31/2021 | 1,232 | 205 | 297 | 353 | N/A |
9/30/2021 | 1,188 | 203 | 273 | 336 | N/A |
6/30/2021 | 1,145 | 187 | 256 | 321 | N/A |
3/31/2021 | 1,096 | 174 | 222 | 286 | N/A |
12/31/2020 | 1,092 | 175 | 218 | 279 | N/A |
9/30/2020 | 1,083 | 149 | 213 | 268 | N/A |
6/30/2020 | 1,103 | 179 | 221 | 274 | N/A |
3/31/2020 | 1,131 | 201 | 211 | 260 | N/A |
12/31/2019 | 1,101 | 187 | 166 | 212 | N/A |
9/30/2019 | 1,047 | 196 | 145 | 187 | N/A |
6/30/2019 | 997 | 173 | 112 | 158 | N/A |
3/31/2019 | 951 | 170 | 94 | 139 | N/A |
12/31/2018 | 911 | 168 | 108 | 155 | N/A |
9/30/2018 | 865 | 175 | 120 | 170 | N/A |
6/30/2018 | 811 | 162 | N/A | 149 | N/A |
3/31/2018 | 771 | 148 | N/A | 168 | N/A |
12/31/2017 | 748 | 139 | N/A | 169 | N/A |
9/30/2017 | 738 | 122 | N/A | 145 | N/A |
6/30/2017 | 728 | 118 | N/A | 145 | N/A |
3/31/2017 | 694 | 105 | N/A | 131 | N/A |
12/31/2016 | 668 | 93 | N/A | 139 | N/A |
9/30/2016 | 657 | 96 | N/A | 130 | N/A |
6/30/2016 | 640 | 87 | N/A | 133 | N/A |
3/31/2016 | 625 | 78 | N/A | 133 | N/A |
12/31/2015 | 611 | 73 | N/A | 120 | N/A |
9/30/2015 | 580 | 83 | N/A | 116 | N/A |
6/30/2015 | 549 | 75 | N/A | 98 | N/A |
3/31/2015 | 521 | 75 | N/A | 94 | N/A |
12/31/2014 | 490 | 65 | N/A | 81 | N/A |
9/30/2014 | 474 | 53 | N/A | 72 | N/A |
6/30/2014 | 459 | 49 | N/A | 70 | N/A |
3/31/2014 | 455 | 46 | N/A | 52 | N/A |
12/31/2013 | 445 | 41 | N/A | 57 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: BIOT 의 연간 예상 수익 증가율( 19.5% )이 saving rate( 1.2% 보다 높습니다. ).
수익 vs 시장: BIOT 의 연간 수익( 19.5% ) Swedish 시장( 15.2% 보다 빠르게 성장할 것으로 예상됩니다. 15.2% 연간).
고성장 수익: BIOT 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.
수익 대 시장: BIOT 의 수익(연간 12.1% ) Swedish 시장( 0.06% 보다 빠르게 성장할 것으로 예상됩니다. 0.06% 연간).
고성장 수익: BIOT 의 수익(연간 12.1% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: BIOT 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 14.3 %).